Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-α

被引:116
作者
García-Ruiz, C
Colell, A
Morales, A
Calvo, M
Enrich, C
Fernández-Checa, JC
机构
[1] Hosp Clin Barcelona, Liver Unit, Inst Malalties Dis, Barcelona 08036, Spain
[2] Univ Barcelona, Dept Cell Biol, Sch Med, Inst Invest Biomed August Pi Suner, E-08036 Barcelona, Spain
[3] CSIC, Dept Expt Pathol, Inst Invest Biomed, Barcelona 08036, Spain
关键词
D O I
10.1074/jbc.M206021200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of mitochondria with proapoptotic proteins activates apoptosis pathways. Previous findings have identified ganglioside GD3 (GD3) as an emerging apoptotic lipid intermediate that targets mitochondria in response to death signals. Using immunoelectron and laser scanning confocal microscopy, we characterize the trafficking of GD3 to mitochondria in response to tumor necrosis factor-alpha (TNF-alpha) in rat hepatocytes. In control hepatocytes, GD3 is present predominantly at the plasma membrane as well as in the endosomal/Golgi network, as verified by its colocalization with the asialoglycoprotein receptor. Following TNF-a exposure, GD3 undergoes a rapid cellular redistribution with a gradual loss from the plasma membrane before its colocalization with mitochondria. This process is mimicked by acidic sphingomyelinase and ionizing radiation but not by neutral sphingomyelinase or staurosporin. TNF-alpha stimulated the colocalization of GD3 with early and late endosomal markers, Rab 5 and Rab 7, whereas perturbation of plasma membrane cholesterol or actin cytoskeleton or inhibition of glucosylceramide synthase prevented the trafficking of GD3 to mitochondria. Finally, prevention of the TNF-alpha-stimulated neosynthesis of GD3, cyclosporin A, and latrunculin A or filipin protected sensitized hepatocytes from TNF-alpha-mediated cell death. Thus, the intracellular redistribution and mitochondrial targeting of GD3 during TNF-alpha signaling occurs through actin cytoskeleton vesicular trafficking and contributes to TNF-alpha-mediated hepatocellular cell death.
引用
收藏
页码:36443 / 36448
页数:6
相关论文
共 56 条
[1]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[2]   Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis [J].
Birbes, H ;
El Bawab, S ;
Hannun, YA ;
Obeid, LM .
FASEB JOURNAL, 2001, 15 (14) :2669-2679
[3]   Apoptosis - Mitochondria - the death signal integrators [J].
Brenner, C ;
Kroemer, G .
SCIENCE, 2000, 289 (5482) :1150-1151
[4]   Morphologic and functional characterization of caveolae in rat liver hepatocytes [J].
Calvo, M ;
Tebar, F ;
Lopez-Iglesias, C ;
Enrich, C .
HEPATOLOGY, 2001, 33 (05) :1259-1269
[5]   Evidence that ganglioside enriched domains are distinct from caveolae in MDCK II and human fibroblast cells in culture [J].
Chigorno, V ;
Palestini, P ;
Sciannamblo, M ;
Dolo, V ;
Pavan, A ;
Tettamanti, G ;
Sonnino, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (13) :4187-4197
[6]   Drosophila grim induces apoptosis in mammalian cells [J].
Clavería, C ;
Albar, JP ;
Serrano, A ;
Buesa, JM ;
Barbero, JL ;
Martínez-A, C ;
Torres, M .
EMBO JOURNAL, 1998, 17 (24) :7199-7208
[7]   Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor [J].
Colell, A ;
Gargía-Ruiz, C ;
Miranda, M ;
Ardite, E ;
Marí, M ;
Morales, A ;
Corrales, F ;
Kaplowitz, N ;
Fernández-Checa, JC .
GASTROENTEROLOGY, 1998, 115 (06) :1541-1551
[8]  
Colell Anna, 2001, FASEB Journal, V15, P1068
[9]   β-amyloid-induced synthesis of the ganglioside Gd3 is a requisite for cell cycle reactivation and apoptosis in neurons [J].
Copani, A ;
Melchiorri, D ;
Caricasole, A ;
Martini, F ;
Sale, P ;
Carnevale, R ;
Gradini, R ;
Sortino, MA ;
Lenti, L ;
De Maria, R ;
Nicoletti, F .
JOURNAL OF NEUROSCIENCE, 2002, 22 (10) :3963-3968
[10]   Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells [J].
De Maria, R ;
Rippo, MR ;
Schuchman, EH ;
Testi, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :897-902